NOVARTIS INDIA
|
NOVARTIS INDIA Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 34.52 | 41.88 | -1.51 | 8.47 | 4.08 |
| CEPS(Rs) | 35.58 | 44.34 | 2.40 | 13.40 | 9.41 |
| DPS(Rs) | 25.00 | 47.50 | 10.00 | 10.00 | 10.00 |
| Book NAV/Share(Rs) | 301.79 | 314.30 | 281.17 | 289.36 | 293.36 |
| Tax Rate(%) | 30.65 | 10.42 | 2.62 | 47.80 | 64.80 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.79 | 15.74 | 5.50 | 5.66 | 2.20 |
| EBIT Margin(%) | 33.89 | 28.33 | 0.21 | 10.52 | 6.58 |
| Pre Tax Margin(%) | 33.49 | 27.90 | -0.78 | 8.82 | 5.38 |
| PAT Margin (%) | 23.22 | 25.00 | -0.76 | 4.61 | 1.89 |
| Cash Profit Margin (%) | 23.93 | 26.46 | 1.22 | 7.29 | 4.36 |
| Performance Ratios | |||||
| ROA(%) | 4.35 | 5.09 | -0.18 | 1.22 | 0.62 |
| ROE(%) | 11.21 | 14.07 | -0.53 | 2.91 | 1.36 |
| ROCE(%) | 16.35 | 15.96 | 0.14 | 6.67 | 4.73 |
| Asset Turnover(x) | 0.19 | 0.20 | 0.23 | 0.26 | 0.33 |
| Sales/Fixed Asset(x) | 10.90 | 10.39 | 8.43 | 5.68 | 9.77 |
| Working Capital/Sales(x) | 0.68 | 0.80 | 0.99 | 0.80 | 0.92 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.09 | 0.10 | 0.12 | 0.18 | 0.10 |
| Receivable days | 38.62 | 35.62 | 31.23 | 30.70 | 28.50 |
| Inventory Days | 49.54 | 49.34 | 39.38 | 42.89 | 40.83 |
| Payable days | 110.74 | 119.32 | 130.52 | 159.09 | 164.16 |
| Valuation Parameters | |||||
| PER(x) | 29.80 | 13.50 | - | 65.18 | 122.97 |
| PCE(x) | 28.91 | 12.75 | 245.74 | 41.21 | 53.38 |
| Price/Book(x) | 3.41 | 1.80 | 2.10 | 1.91 | 1.71 |
| Yield(%) | 2.43 | 8.40 | 1.69 | 1.81 | 1.99 |
| EV/Net Sales(x) | 5.80 | 2.22 | 2.35 | 2.26 | 1.50 |
| EV/Core EBITDA(x) | 15.30 | 6.81 | 15.58 | 14.42 | 13.65 |
| EV/EBIT(x) | 15.62 | 7.16 | 930.30 | 18.09 | 18.77 |
| EV/CE(x) | 2.61 | 1.08 | 0.47 | 0.39 | 0.53 |
| M Cap / Sales | 7.58 | 3.68 | 3.64 | 3.57 | 2.83 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -11.53 | -5.28 | 4.86 | -12.98 | -10.69 |
| Core EBITDA Growth(%) | 3.04 | 104.30 | 0.70 | 24.31 | -46.80 |
| EBIT Growth(%) | 6.15 | - | -97.88 | 36.23 | -59.90 |
| PAT Growth(%) | -17.58 | 2,878.49 | -117.80 | 107.34 | -80.53 |
| EPS Growth(%) | -17.58 | 2,878.48 | -117.80 | 107.34 | -80.53 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.36 | 2.93 | 2.47 | 2.58 | 2.39 |
| Quick Ratio(x) | 2.24 | 2.73 | 2.30 | 2.45 | 2.25 |
| Interest Cover(x) | 83.44 | 66.93 | 0.21 | 6.21 | 5.48 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹2,533.7 Cr | -3.4% | -1.4% | 47.4% | Stock Analytics | |
| ADANI ENTERPRISES | ₹257,342.0 Cr | -21.1% | -21.1% | -1.2% | Stock Analytics | |
| REDINGTON | ₹15,221.2 Cr | 0.7% | 15% | 21% | Stock Analytics | |
| MMTC | ₹11,148.0 Cr | -1.4% | -1.5% | 42.1% | Stock Analytics | |
| HONASA CONSUMER | ₹7,285.8 Cr | -39.3% | -44.7% | -28.5% | Stock Analytics | |
| MSTC | ₹4,412.7 Cr | 7.5% | -8.5% | 36.9% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | -3.4% |
-1.4% |
47.4% |
| SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses
